Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Small molecule nerve growth factor analogs image receptors in vivo

Abstract

The in vivo targeting efficacy of small molecule analogs of nerve growth factor (NGF) that bind the NGF receptor p140 TrkA was evaluated and compared with that of a high-affinity anti-TrkA monoclonal antibody (Mab 5C3). Nuclear imaging studies were done after the injection of 99mTc-labeled compounds in nude mice bearing tumors. Kinetics of tumor targetting, blood clearance, and bioavailability of NGF mimics were equivalent or better than Mab 5C3. Tumors that do not express TrkA were not targeted, demonstrating the specificity of NGF mimics in vivo. This comparative biodistribution study demonstrates that receptor-specific small molecule analogs designed from large polypeptides may be more useful than antibodies and may be effective agents for the detection, diagnosis, and possible treatment of neoplasias involving overexpressed oncogenic receptors such as TrkA.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Schwartz, D.A., Abrams, M.J., Mauser, M.M., Gaul, F.E., Larsen, S.K., Rauh, D. et al. 1991. Preparation of hydrazino-modified proteins and their use for the synthesis of 99mTc-protein conjugates. Bioconjugate Chemistry 2: 333–336.

    Article  CAS  Google Scholar 

  2. Saragovi, H.U. and Greene, M.I. 1992. Constrained peptides and mimetics as probes of protein secondary structure. Immunomethods 1: 3–12.

    Article  Google Scholar 

  3. Zhang, X., Piatier-Tonneau, D., Auffray, C., Murali, R., Mahapatra, A., Zhang, F. et al. 1996. Synthetic CD4 exocyclic peptides antagonize CD4 holoreceptor binding and T cell activation. Nature Biotechnology 14: 472–475.

    Article  CAS  Google Scholar 

  4. Barbacid, M. 1994. The Trk family of neurotrophin receptors. J. Neurobiol. 25: 1386–1403.

    Article  CAS  Google Scholar 

  5. Nakagawara, A., Arima-Nakagawara, M., Scavarda, N.J., Azar, C.G., Cantor, A.B. and Brodeur, G.M. 1993. Association between high levels of expression of the Trk gene and favorable outcome in human neuroblastoma. N. Engl. J. of Med. 328: 847–854.

    Article  CAS  Google Scholar 

  6. Oelman, E., Sreter, L., Schuller, I., Serve, H., Uoenigsann, M., Wiedmann, B. et al. 1995. Nerve growth factor stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expressing high affinity nerve growth factor binding sites involving tyrosine kinase signalling. Cancer Res. 55: 2212–2219.

    Google Scholar 

  7. Marchetti, D., Menter, D., Jin, L., Nakajima, M. and Nicolson, G.L. 1993. Nerve growth factor effects on human and mouse melanoma cell invasion and hepa-ranase production. Intl. J. Cancer 55: 692–699.

    Article  CAS  Google Scholar 

  8. LeSauteur, L., Wei, L., Gibbs, B. and Saragovi, H.U. 1995. Small peptide mimics of nerve growth factor bind TrkA receptors and affect biological responses. J. Biol. Chem. 270: 6564–6569.

    Article  CAS  Google Scholar 

  9. LeSauteur, L., Wei, L., Gibbs, B. and Saragovi, H.U. 1996. Small peptide mimics of nerve growth factor bind TrkA receptors and affect biological responses (addition and correction). J. Biol. Chem. 271: 249.

    Article  Google Scholar 

  10. LeSauteur, L., Maliartchouk, S., LeJeune, H., Quirion, R. and Saragovi, H.U. 1996. Potent human p140-TrkA agonists derived from an anti-receptor monoclonal antibody. J. Neurosci. 16: 1308–1316.

    Article  CAS  Google Scholar 

  11. Jing, S., Tapley, P. and Barbacid, M. 1992. Nerve growth factor mediates signal transduction through Trk homodimer receptors. Neuron 9: 1067–1079.

    Article  CAS  Google Scholar 

  12. Yasumura, Y., Buonsassisi, V. and Sato, G. 1966. Clonal analysis of differentiated function in animal cell cultures. I. Possible correlated maintenance of differentiated function and the diploid karyotype. Cancer Res. 26: 529–535.

    CAS  PubMed  Google Scholar 

  13. Michitsch, R.W., Biedler, J.L. and Melera, P.W. 1988. Modulation of N-myc expression, but not tumorigenicity, accompanies phenotypic conversion of neuroblastoma cells in prolonged culture, pp. 103–120 in Advances in neuroblastoma research 2. Evans, A.E., D'Angio, G.J., Knudson, A.G., and Seeger, R.C. (eds.). Progress in clinical and biological research. Vol 271. Alan R. Liss, Inc, NY.

    Google Scholar 

  14. Fujimori, K., Fisher, D.R. and Weinstein, J.N. 1991. Integrated microscopic/macroscopic pharmacology of monoclonal antibody radioconjugates: the radiation dose distribution. Cancer Res. 51: 4821–4827.

    CAS  PubMed  Google Scholar 

  15. Lomen-Hoerth, C. and Shooter, E.M. 1995. Widespread neurotrophin receptor expression in the immune system and other non-neuronal rat tissues. J. Neurochem. 64: 1780–1789.

    Article  CAS  Google Scholar 

  16. Esteban, I., Hannestad, J., Levanti, B., DelValle, M.E., Naves, F.J. and Vega, J.A. 1995. Neurotrophin receptor proteins immunoreactivity in human gastrointestinal endocrine cells. Brain Res. Bulletin 38: 539–543.

    Article  CAS  Google Scholar 

  17. Trail, P.A., Willner, D., Lasch, S.J., Henderson, A.J., Hofstead, S., Casazza, A.M. et al. 1993. Cure of xenografted human carcinomas by BR96-doxorubicin Immunoconjugates. Science 261: 212–215.

    Article  CAS  Google Scholar 

  18. Cheung, N.K., Kushner, B.H., Yeh, S.J. and Larson, S.M. 1994. 3F8 monoclonal antibody treatment of patients with stage IV neuroblastoma: a phase II study. Progress in Clinical and Biological Research 385: 319–338.

    CAS  PubMed  Google Scholar 

  19. Saragovi, H.U., Fitzpatrick, D., Raktabutr, A., Nakanishi, H., Kahn, M. and Greene, M.I. 1991. Design and synthesis of a mimetic from an antibody complementarity-determining region. Science 253: 792–795.

    Article  CAS  Google Scholar 

  20. Saragovi, H.U., Greene, M.I., Chrusciel, R.A. and Kahn, M. 1992. Loops and secondary structure mimetics: development and applications in basic science and rational drug design. Bio/Technology 10: 773–778.

    CAS  PubMed  Google Scholar 

  21. Kramer, K., Gerald, W., LeSauteur, L., Saragovi, H.U. and Cheung, N.-K.V. 1996. Prognostic value of TrkA protein detection by monoclonal antibody 5C3 in neuroblastoma. Clin. Cancer Res. In press.

  22. King, T.R., Zhao, S.W. and Lam, T. 1986. Preparation of protein conjugates via intermolecular hydrazone linkage. Biochemistry 25: 5774–5779.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

LeSauteur, L., Cheung, NK., Lisbona, R. et al. Small molecule nerve growth factor analogs image receptors in vivo. Nat Biotechnol 14, 1120–1123 (1996). https://doi.org/10.1038/nbt0996-1120

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0996-1120

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing